Evidence map›Paper›PMID 28634346›Full record

ArticleScientific reports2017

Generating conditional gene knockouts in Plasmodium - a toolkit to produce stable DiCre recombinase-expressing parasite lines using CRISPR/Cas9.

Ellen Knuepfer, Marta Napiorkowska, Christiaan van Ooij, Anthony A Holder

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The essential function of the apical polar ring during the blood stage ofbioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Evaluation ofiScience · 2025
    Article
  15. Article
  16. Article
  17. Organoid-basedMicrobiology spectrum · 2025
    Article
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Ellen KnuepferMalaria Parasitology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom. Ellen.Knuepfer@crick.ac.uk.
Marta NapiorkowskaMalaria Biochemistry Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom.
Christiaan van OoijMalaria Biochemistry Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom. Christiaan.vanOoij@crick.ac.uk.ORCID 0000-0002-6099-6183
Anthony A HolderMalaria Parasitology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom. Tony.Holder@crick.ac.uk.
The Francis Crick Institute · GB

Funding

Wellcome Trust FC001097
6 · The paper itself

Abstract

Successful establishment of CRISPR/Cas9 genome editing technology in Plasmodium spp. has provided a powerful tool to transform Plasmodium falciparum into a genetically more tractable organism. Conditional gene regulation approaches are required to study the function of gene products critical for growth and erythrocyte invasion of blood stage parasites. Here we employ CRISPR/Cas9 to facilitate use of the dimerisable Cre-recombinase (DiCre) that is frequently used to mediate the excision and loss of loxP-flanked DNA sequences in a rapamycin controlled manner. We describe novel CRISPR/Cas9 transfection plasmids and approaches for the speedy, stable and marker-free introduction of transgenes encoding the DiCre recombinase into genomic loci dispensable for blood stage development. Together these plasmids form a toolkit that will allow the rapid generation of transgenic DiCre-expressing P. falciparum lines in any genetic background. Furthermore, the newly developed 3D7-derived parasite lines, constitutively and stably expressing DiCre, generated using this toolkit will prove useful for the analysis of gene products. Lastly, we introduce an improved treatment protocol that uses a lower rapamycin concentration and shorter treatment times, leading to loxP-guided recombination with close to 100% efficiency within the same replication cycle.

Indexed as

CRISPR-Cas SystemsGene ExpressionAnimalsAnimals, Genetically ModifiedGene EditingGene Knockout TechniquesGenes, ReporterGenome, ProtozoanIntegrasesPlasmidsPlasmodiumPlasmodium falciparumRecombination, GeneticCre recombinaseIntegrases

Identifiers

PMID28634346
PMCPMC5478596
OpenAlexW2677447961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.